What You Should Know:
– Vitestro, the pioneering autonomous blood drawing company, today announced that it has raised $22 million (€20 million) funding to accelerate commercialization of its innovative robotic blood drawing device.
– This brings its total funding raised to $50 million (€46 million) from both equity investments and grant funding.
Vitestro Secures Oversubscribed Funding Round to Drive European Expansion and U.S. Market Entry
Led by returning investor Sonder Capital and newcomer NYBC Ventures, alongside Invest-NL, the European Innovation Council Fund (EIC Fund), and existing private investors, the oversubscribed funding round will propel Vitestro’s European commercialization and facilitate its organizational expansion into the U.S. market.
Utilizing a blend of artificial intelligence (AI), advanced imaging technology, and robotics, Vitestro empowers hospitals and laboratories to conduct precise and autonomous blood draws, minimizing manual intervention and enhancing both patient and clinician satisfaction. Several Vitestro devices have already been pre-ordered and are slated for deployment in various European hospitals later this year, aiming to alleviate workloads and enhance patient experiences consistently.
Moreover, Vitestro currently spearheads the A.D.O.P.T. trial, the largest assessment of autonomous blood drawing devices worldwide. The recent funding infusion will enable Vitestro to bolster its team to meet escalating demand for its groundbreaking robotic blood drawing device and pioneer additional product enhancements. With plans underway to secure CE approval for its device by the close of 2024, Vitestro anticipates commencing deployment efforts within the same timeframe.
“We are honored to continue working with Sonder Capital and proud to welcome NYBC Ventures, Invest-NL, and EIC Fund to the Vitestro team,” said Toon Overbeeke, Vitestro CEO and co-founder. “Early feedback from hospitals, staff and patients has been overwhelmingly positive, and we are eager to quickly expand our reach and impact globally.”